FTSE All-Share
5.504,53
PKT
-21,74
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.11.24 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 22.11.24 | Unilever Sell | UBS AG | |
| 22.11.24 | Unilever Sector Perform | RBC Capital Markets | |
| 21.11.24 | Unilever Sell | UBS AG | |
| 21.11.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 20.11.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.11.24 | AstraZeneca Neutral | UBS AG | |
| 19.11.24 | HSBC Equal Weight | Barclays Capital | |
| 19.11.24 | Rio Tinto Neutral | UBS AG | |
| 18.11.24 | BP Buy | Goldman Sachs Group Inc. | |
| 15.11.24 | GSK Hold | Deutsche Bank AG | |
| 15.11.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 15.11.24 | BP Buy | Jefferies & Company Inc. | |
| 15.11.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 14.11.24 | Vodafone Group Halten | DZ BANK | |
| 14.11.24 | National Grid Buy | UBS AG | |
| 14.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.11.24 | AstraZeneca Halten | DZ BANK | |
| 13.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 13.11.24 | Vodafone Group Buy | Deutsche Bank AG | |
| 13.11.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 13.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | HSBC Sector Perform | RBC Capital Markets | |
| 12.11.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 12.11.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | AstraZeneca Sell | UBS AG | |
| 12.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | Vodafone Group Neutral | UBS AG | |
| 12.11.24 | Vodafone Group Underperform | Bernstein Research | |
| 12.11.24 | GSK Hold | Jefferies & Company Inc. | |
| 11.11.24 | National Grid Outperform | RBC Capital Markets | |
| 08.11.24 | National Grid Buy | Deutsche Bank AG | |
| 08.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | BP Underweight | JP Morgan Chase & Co. | |
| 08.11.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 07.11.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 07.11.24 | National Grid Buy | UBS AG |